Join
Live feed
·
INSIDERFilingvia Quantisnow
Turning Point Therapeutics Inc. logo

SEC Form 4: Partridge Andrew John sold $8,022 worth of shares (221 units at $36.30) and was granted 16,283 shares, increasing direct ownership by 72% to 38,361 units (withholding obligation)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TPTX (Turning Point Therapeutics Inc.) and more on Quantisnow.